Cost and energy-efficient repositioning of office buildings to Pharma/Lab Spaces.
Acquisition of quality assets and quality locations at distressed prices.
Currently Seeking Capital - Target $50-100 million.
Targeting high-quality South Eastern US development assets. The object is to replace the capital gap due to tightened credit standards. Targeting equity-like returns with bond-like collateralized assets.
We are actively seeking companies with proven products and high growth potential